Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Symonds

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancerA J Colquhoun, S Sundar, P H Rajjayabun, et al.
Cancer Treatment Reviews|July 13, 2004
Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic reviewR P Symonds, M Collingwood, J Kirwan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1990
Oestrogen and progesterone receptors in carcinoma of the cervixM Harding, J McIntosh, J Paul, et al.
Gynecologic Oncology|August 7, 2004
Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapyS Sundar, R P Symonds, M P Decatris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2006
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaborationC E Humber, J F Tierney, R P Symonds, et al.
British Journal of Cancer|October 1, 1996
Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rateB S Bolger, R P Symonds, P D Stanton, et al.
Gynecologic Oncology|July 5, 2011
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancerR P Symonds, S E Davidson, S Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?B T Sherwood, G D D Jones, J K Mellon, et al.
ESMO Real World Data and Digital Oncology|March 19, 2026
Prediction models of adverse outcomes following surgery and radiotherapy for breast cancer: a systematic reviewH Asfour, B Wang, H Zhou, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neckM Q Hatton, E J Junor, J Paul, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Epidermal growth factor receptor status predicts local response to radical radiotherapy in muscle-invasive bladder cancerA J Colquhoun, S Sundar, P H Rajjayabun, et al.
Cancer Treatment Reviews|July 13, 2004
Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic reviewR P Symonds, M Collingwood, J Kirwan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1990
Oestrogen and progesterone receptors in carcinoma of the cervixM Harding, J McIntosh, J Paul, et al.
Gynecologic Oncology|August 7, 2004
Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapyS Sundar, R P Symonds, M P Decatris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2006
Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaborationC E Humber, J F Tierney, R P Symonds, et al.
British Journal of Cancer|October 1, 1996
Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rateB S Bolger, R P Symonds, P D Stanton, et al.
Gynecologic Oncology|July 5, 2011
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancerR P Symonds, S E Davidson, S Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?B T Sherwood, G D D Jones, J K Mellon, et al.
ESMO Real World Data and Digital Oncology|March 19, 2026
Prediction models of adverse outcomes following surgery and radiotherapy for breast cancer: a systematic reviewH Asfour, B Wang, H Zhou, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1996
Carboplatin, 5-fluorouracil and folinic acid: a 48-hour chemotherapy regimen in advanced and recurrent squamous carcinoma of the head and neckM Q Hatton, E J Junor, J Paul, et al.
Pageof 10